SELECT TOP (1000) [Source] ,[Taxon] ,[LowValue] ,[HighValue] ,[LowPCile] ,[HighPCile] FROM [DB_A5D9F7_Lassesen].[dbo].[JasonH]

Archaea Details: NCBI 2157, gram-negative or unknown [superkingdom]

| "Archaea" Woese et al. 1990| "Archaebacteria" (sic) Woese and Fox 1977| Archaea| Archaebacteria| Mendosicutes| Metabacteria| Monera| Procaryotae| Prokaryota| Prokaryotae| prokaryote| prokaryotes

  1. Extreme environments: Archaea are known for their ability to thrive in extreme environments where other organisms would struggle to survive. Some Archaea are extremophiles, capable of surviving in conditions of high temperature, extreme pH levels, high salinity, or high pressure. While these extreme environments may not directly impact human health, studying extremophilic Archaea can provide insights into the limits of life and the potential for life on other planets.

  2. Gut microbiota: While Bacteria dominate the gut microbiota, Archaea are also present in the human gut, albeit in much smaller numbers. Methanogens, a group of Archaea capable of producing methane as a metabolic byproduct, are found in the human digestive system. They interact with other microorganisms and contribute to the fermentation process in the gut. Although their role in the gut microbiota is not fully understood, they may indirectly influence human health through their interactions with other microbes and their metabolic activities.

  3. Biotechnological applications: Some Archaea have biotechnological applications, particularly in the fields of bioremediation and biofuel production. For example, certain Archaea are capable of metabolizing hydrocarbons and may be used to clean up oil spills or degrade pollutants in contaminated environments. Others produce enzymes with industrial applications, such as extremozymes that function under extreme conditions of temperature or pH.

  4. Disease association: While Archaea are not typically considered human pathogens, some studies have suggested associations between Archaea and certain diseases. For example, Methanobrevibacter smithii, a methanogen found in the human gut, has been implicated in conditions such as obesity and inflammatory bowel disease (IBD). However, the exact role of Archaea in these diseases and whether they contribute directly to pathology or are simply markers of dysbiosis (imbalance in the gut microbiota) is still under investigation.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

More Information
Statistics NCBI Data Punk End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Archaea

These are values that are computed from lab specific samples (Patent Pending)
LabFrequencyUD-LowUD-HighKM LowKM HighLab LowLab HighMean MedianStandard DeviationBox Plot LowBox Plot High KM Percentile Low KM Percentile High
Other Labs 4.15 0 0 1 1000000 0 262499 29471.1 924 118891.9 0 31476 0 %ile 100 %ile
biomesight 26.07 0 20 20 8730 0 10767 1423.2 285 4767.1 0 1830 8 %ile 97.1 %ile
thorne 17.24 1 4 0 5 2.4 2 1.1 1 4 14.3 %ile 71.4 %ile
thryve 23.74 0 18 1 5585 0 17307 3512.3 738 7038.4 0 6078 0 %ile 92 %ile
ubiome 28.9 0 585 21 109569 0 52866 14698.1 7116 19473.7 0 32163 0 %ile 100 %ile

External Reference Ranges for Archaea

Archaea (NCBI 2157) per million
Source of Ranges Low Boundary High Boundary Low Boundary %age High Boundary %age
Statistic by Lab Source for Archaea
These desired values are reported from the lab reports
Lab Frequency Seen Average Standard Deviation Sample Count Lab Samples
AmericanGut 60 %   0.107 %  0.199 % 9.0 15
BiomeSight 27.025 %   0.125 %  0.433 % 774.0 2864
BiomeSightRdp 53.125 %   0.054 %  0.194 % 17.0 32
bugspeak 100 %   0.02 %  % 1.0 1
CerbaLab 66.667 %   0 %  0 % 2.0 3
CosmosId 9.375 %   0.888 %  1.035 % 3.0 32
custom 54.237 %   0.815 %  0.854 % 32.0 59
es-xenogene 72.414 %   7.395 %  24.217 % 21.0 29
GanzimmunDiag 100 %   0.021 %  0 % 3.0 3
Medivere 100 %   0.946 %  1.934 % 7.0 7
Microba 14.286 %   0.655 %  0.71 % 4.0 28
Microba1 100 %   2.67 %  % 1.0 1
SequentiaBiotech 52.778 %   4.894 %  5.597 % 19.0 36
Thorne 9.091 %   0.101 %  0.283 % 8.0 88
Thryve 22.993 %   0.334 %  0.701 % 318.0 1383
Tiny 100 %   0.006 %  % 1.0 1
uBiome 28.914 %   1.479 %  1.948 % 229.0 792

Symptoms Associated with Archaea From Citizen Science Studies

Click on Impact for information if high or low levels are causing the impact

MagnitudeImpactSymptom

To see medical conditions associated you may be logged in

And display level must be raised above public.

Foods Containing the Archaea bacteria

Data comes from FoodMicrobionet. For the meaning of weight, see that site. The bacteria does not need to be alive to have an effect.

Sausage, Cyprus: Paphos Weight: 0.02036 Sausage, Cyprus: Limassol Weight: 0.008564

I would like to know what can change the quality that I have

Data Contradictions β€” Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

πŸ§™? Search Hints:
General Substance Specific Substance Effect
Common Supplements Exercise 1 Studies recorded. The consensus is Increases👪, Click for details.
Diet Style low protein diet 1 Studies recorded. The consensus is Increases👪, Click for details.
Vitamins, Minerals and similar zinc 1 Studies recorded. The consensus is Increases👪, Click for details.

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)